Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Solid Biosciences Inc. SLDB
$6.34
-$0.1 (-1.55%)
На 18:00, 12 мая 2023
+1 792.74%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
125463571.00000000
-
week52high
14.25
-
week52low
3.40
-
Revenue
8094000
-
P/E TTM
-1
-
Beta
1.47404800
-
EPS
-11.02000000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 мая 2023 г. в 12:30
Описание компании
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Chardan Capital | Buy | Buy | 12 авг 2022 г. |
| Piper Sandler | Neutral | Neutral | 19 мая 2022 г. |
| SVB Leerink | Outperform | Outperform | 28 апр 2022 г. |
| Piper Sandler | Neutral | Neutral | 28 апр 2022 г. |
| Chardan Capital | Buy | Buy | 28 апр 2022 г. |
| JP Morgan | Neutral | Underweight | 30 сент 2022 г. |
| SVB Leerink | Market Perform | Outperform | 17 окт 2022 г. |
| Piper Sandler | Neutral | Neutral | 11 ноя 2022 г. |
| Barclays | Overweight | Overweight | 11 ноя 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 10 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Ganot Ilan | D | 11650 | 3883 | 27 янв 2023 г. |
| Ganot Ilan | D | 1165 | 388 | 27 янв 2023 г. |
| Ganot Ilan | D | 84591 | 1382 | 27 янв 2023 г. |
| Ganot Ilan | A | 85973 | 3883 | 27 янв 2023 г. |
| Ganot Ilan | D | 1378 | 141 | 27 янв 2023 г. |
| Ganot Ilan | A | 1519 | 388 | 27 янв 2023 г. |
| Morris Carl Ashley | D | 3700 | 1233 | 27 янв 2023 г. |
| Morris Carl Ashley | D | 19760 | 441 | 27 янв 2023 г. |
| Morris Carl Ashley | A | 20201 | 1233 | 27 янв 2023 г. |
| Tan Kevin | A | 45000 | 45000 | 09 янв 2023 г. |
Новостная лента
Solid Biosciences to Present at JMP Securities Life Sciences Conference
GlobeNewsWire
08 мая 2023 г. в 16:05
CHARLESTOWN, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference on Monday, May 15, 2023 at 1:00 PM ET.
Solid Biosciences to Present at the 22nd Annual Needham Healthcare Conference
GlobeNewsWire
13 апр 2023 г. в 08:00
CHARLESTOWN, Mass. , April 13, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the 22nd Annual Needham Healthcare Conference on Thursday, April 20, 2023 at 8:00 AM ET.
Solid Biosciences to Present at Barclays Global Healthcare Conference
GlobeNewsWire
07 мар 2023 г. в 08:00
CHARLESTOWN, Mass., March 07, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2023, at 3:35 PM ET.
Solid Biosciences to Present at SVB Securities Global Biopharma Conference
GlobeNewsWire
08 февр 2023 г. в 08:00
CHARLESTOWN, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023, at 1:40 pm ET.
Solid Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
09 янв 2023 г. в 08:00
CAMBRIDGE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 9:00 am PT / 12:00 pm ET.